- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Study Points to Lack of Awareness on the BRCA-Ovarian Cancer Relation
75 percent of those at high risk for BRCA mutations have no idea they may have increased chance of ovarian cancer, drawing attention to the importance of genetic counseling.
Any woman who’s watched her mother or sister struggle with breast cancer knows that she’s likely at high risk for the disease herself. But what she probably doesn’t realize is that she may have an increased chance of ovarian cancer as well, according to a new study by Fred Hutchinson Cancer Research Center scientists.
In an analysis of nearly 1,900 Seattle-area women with family histories that could suggest dangerous BRCA1 or BRCA2 genetic mutations that raise cancer risk, nearly two-thirds of those surveyed knew they should be worried about breast cancer — but more than 75 percent had no idea they should be concerned about ovarian cancer as well.
Those were startling findings to Dr. Robyn Andersen, an expert in ovarian cancer symptoms and screening in Fred Hutch’s Public Health Sciences division. She found that in the more than 15 years since BRCA testing has been available, awareness among high-risk women of ovarian cancer hadn’t budged, even though the American Cancer Society estimates the disease will be diagnosed in nearly 22,000 U.S women this year and will kill more than 14,000.
Read the new here: http://bit.ly/1q32Sca
Source: Fred Hutchison Cancer Research Center
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Uniting to Support Patients With Cancer Beyond Treatment
November 17th 2024Kasey Bond, MPH, of Perlmutter Cancer Center at NYU Langone Health, speaks to why it’s vital to keep patients at the center of all strategic partnerships between academic institutions and community-based oncology practices.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Bridging Cancer Care Gaps and Overcoming Medical Mistrust
November 13th 2024In this clip from our interview with Oscar B. Lahoud, MD, cochair of our Institute for Value-Based Medicine® evening hosted with NYU Langone Health, he addressed medical mistrust in underrepresented communities.
Read More
How English- and Spanish-Preferring Patients With Cancer Decide on Emergency Care
November 13th 2024Care delivery innovations to help patients with cancer avoid emergency department visits are underused. The authors interviewed English- and Spanish-preferring patients at 2 diverse health systems to understand why.
Read More
